Application 214108
- Type
- ANDA
- Sponsor
- RUBICON
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | FOR SOLUTION;ORAL | 20MEQ | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214108-001 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 20MEQ | FOR SOLUTION / ORAL | AA | 2022-03-24 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A214108-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A214108-001 | POTASSIUM CHLORIDE | 20MEQ | FOR SOLUTION / ORAL | AA | 2022-03-24 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A214108-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride | POTASSIUM CHLORIDE | Advagen Pharma Limited | d528c0c1-b81f-4f7a-8518-e6911b23c3eb | 2026-01-13 | Warnings, Adverse reactions | 214108 ANDA214108 72888-024 |
| Potassium Chloride | POTASSIUM CHLORIDE | Northstar Rx LLC | fbed8c29-b3f1-4e53-b290-6f717290cecf | 2025-10-07 | Warnings, Adverse reactions | 214108 ANDA214108 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 72888-024 | Potassium Chloride | Potassium Chloride | Advagen Pharma Limited | ANDA | Current |